As of 2024-07-27, the Relative Valuation of Insmed Inc (INSM) is (141.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 74.54 USD, the upside of Insmed Inc based on Relative Valuation is -290.3%.
The range of the Relative Valuation is (140.88) - (144.54) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 35.0x | 31.3x |
| Forward P/E multiples | 29.0x - 31.6x | 30.6x |
| Fair Price | (140.88) - (144.54) | (141.86) |
| Upside | -289.0% - -293.9% | -290.3% |
| Date | P/E |
| 2024-07-26 | -16.28 |
| 2024-07-25 | -16.27 |
| 2024-07-24 | -16.25 |
| 2024-07-23 | -16.59 |
| 2024-07-22 | -16.66 |
| 2024-07-19 | -16.59 |
| 2024-07-18 | -16.39 |
| 2024-07-17 | -16.49 |
| 2024-07-16 | -17.03 |
| 2024-07-15 | -16.92 |
| 2024-07-12 | -16.75 |
| 2024-07-11 | -16.82 |
| 2024-07-10 | -15.96 |
| 2024-07-09 | -15.34 |
| 2024-07-08 | -15.30 |
| 2024-07-05 | -15.28 |
| 2024-07-03 | -13.54 |
| 2024-07-02 | -14.08 |
| 2024-07-01 | -14.48 |
| 2024-06-28 | -14.63 |
| 2024-06-27 | -14.62 |
| 2024-06-26 | -15.06 |
| 2024-06-25 | -15.22 |
| 2024-06-24 | -14.94 |
| 2024-06-21 | -14.85 |
| 2024-06-20 | -14.13 |
| 2024-06-18 | -14.32 |
| 2024-06-17 | -14.13 |
| 2024-06-14 | -13.96 |
| 2024-06-13 | -13.46 |
| 2024-06-12 | -13.46 |
| 2024-06-11 | -13.51 |
| 2024-06-10 | -13.08 |
| 2024-06-07 | -12.41 |
| 2024-06-06 | -12.48 |
| 2024-06-05 | -12.63 |
| 2024-06-04 | -12.45 |
| 2024-06-03 | -12.21 |
| 2024-05-31 | -12.02 |
| 2024-05-30 | -12.44 |
| 2024-05-29 | -11.69 |
| 2024-05-28 | -10.49 |
| 2024-05-24 | -4.80 |
| 2024-05-23 | -5.15 |
| 2024-05-22 | -5.28 |
| 2024-05-21 | -5.36 |
| 2024-05-20 | -5.58 |
| 2024-05-17 | -5.41 |
| 2024-05-16 | -5.48 |
| 2024-05-15 | -5.44 |